Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT04902560
Brief Summary:
Sexual health centers (CeGIDD, in France) manage the majority of STI in France, especially gonorrhea.
Patients wanting STI screening can consult either they are symptomatic or not.
If they are symptomatic, they can be treated immediately. If they are not symptomatic, they must come back seven days after in order to get their results and to be treated if necessary.
Before any treatment for gonorrhea, subjects should be sampled for bacterial culture in order to perform AMR surveillance.
After every treatment for gonorrhea, subjects should realized a test of cure (TOC) according to current recommandation.
Response rate to ceftriaxone 1g IM for treating gonorrhea has never been evaluated in France while being used widely over the past months.
Compliance to current recommandation at CeGIDD Montpellier has never been evaluated.
This study will assess the response rate to ceftriaxone 1g IM as gonorrhea treatment by realizing a test of cure 14 days after each treatment.
Study:
NCT04902560
Study Brief:
Protocol Section:
NCT04902560